Lancet. 1976 Jan 24;1(7952):162-3.
Totals of 404 Chinese and 778 East African patients with newly diagnosed drug-sensitive pulmonary tuberculosis were treated with short-course regiments of antituberculosis chemotherapy. The Chinese received 6-month and 9-month regimens of streptomycin plus isoniazid plus pyrazinamide, and the East Africans 6-month regiments of streptomycin plus isoniazid alone or with a third drug. 28 Chinese and 45 African patients who relapsed with drug-sensitive strains after their short-course regimen were retreated with standard first-line chemotherapy. The Chinese were given every single dose under full supervision, but the Africans the initial phase only. At 12 months from the start of their retreatment, all 28 Chinese and 40 (89%) of the 45 Africans had a favourable therapeutic response on their retreatment regimen. 2 of the 5 East African patients whose retreatment failed were known to have been irregular in taking their drugs.
404名中国患者和778名东非新诊断出的药物敏感性肺结核患者接受了短程抗结核化疗方案治疗。中国患者接受了为期6个月和9个月的链霉素加异烟肼加吡嗪酰胺方案,东非患者接受了为期6个月的链霉素加异烟肼方案,单独使用或加用第三种药物。28名中国患者和45名非洲患者在短程治疗方案后对药物敏感菌株复发,接受了标准一线化疗。中国患者的每一剂药物都在全程监督下服用,但非洲患者仅在初始阶段接受监督。在重新治疗开始后的12个月时,所有28名中国患者和45名非洲患者中的40名(89%)对重新治疗方案有良好的治疗反应。已知5名重新治疗失败的东非患者中有2名服药不规律。